Acute Investment Advisory’s Innovator US Equity Buffer ETF September BSEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-149,892
Closed -$4.89M 30
2022
Q1
$4.89M Buy
+149,892
New +$4.81M 3.65% 7

Other funds holding BSEP

Acute Investment Advisory's BSEP Position: Q2 2022 in Review

Acute Investment Advisory sold out of Innovator US Equity Buffer ETF September (BSEP) in Q2 2022, closing a stake of 149,892 shares — an estimated $4.89M sold.

Acute Investment Advisory first reported a position in BSEP in Q1 2022 and held it in 1 quarter. The position peaked at $4.89M in Q1 2022. 65 funds tracked by Wall St. Rank hold BSEP as of Q2 2022.

  • Acute Investment Advisory reported no remaining Innovator US Equity Buffer ETF September position as of Q2 2022 after selling out during the quarter.
  • Acute Investment Advisory sold 149,892 Innovator US Equity Buffer ETF September shares in Q2 2022, an estimated $4.89M.
  • Acute Investment Advisory first reported a position in Innovator US Equity Buffer ETF September in Q1 2022 and held it in 1 quarter.
  • Acute Investment Advisory's Innovator US Equity Buffer ETF September position peaked at $4.89M in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF September as of Q2 2022.

Based on Acute Investment Advisory's 13F filing for Q2 2022, filed 31 Aug 2022.